Researchers have identified a new weakness tied to DNA repair in aggressive, drug-resistant cancers. The study suggests that some hard-to-treat tumor cells survive anticancer drugs by using a previously unrecognized protective strategy linked to fixing damaged DNA.
According to the report, these cancers appear to hijack specific DNA repair defenses to avoid being killed by treatment. That matters because repairing DNA damage is one of the ways cancer cells can withstand the effects of many anticancer medicines, especially in tumors that have already become difficult to treat.
The finding stands out because the newly described defense system may be easier to block than other known mechanisms involved in DNA repair. If that proves true in further research, it could give scientists a more practical target for therapies designed to weaken resistant cancer cells and make existing drugs work better.
While the study does not mean a new treatment is immediately available, it adds an important clue to how aggressive cancers escape therapy. By uncovering a more vulnerable part of the DNA repair process, the research points to a possible new approach for tackling drug resistance in cancer.
